First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis

Roberto Adriano Latini; Dario Buccheri; Bernardo Cortese

doi:10.1002/ccd.26803

First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis

Catheter Cardiovasc Interv. 2017 Mar 1;89(4):676-678. doi: 10.1002/ccd.26803. Epub 2016 Sep 21.

Authors

Roberto Adriano Latini¹, Dario Buccheri², Bernardo Cortese^{1

3}

Affiliations

¹ Department of Interventional Cardiology, ASST Fatebenefratelli Sacco, Milan, Italy.
² Department of Interventional Cardiology, University Hospital, Policlinic "P.Giaccone" Palermo, Italia.
³ Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Massa, Italy.

PMID: 27649683
DOI: 10.1002/ccd.26803

Abstract

This is the first documented case of a drug-coated balloon strategy for the treatment of bioresorbable in-scaffold restenosis caused by diffuse neointimal proliferation. This case can provide an alternative treatment option in this setting, avoiding potential problems related to further bulky metallic stents in a patient where a different strategy was initially planned. © 2016 Wiley Periodicals, Inc.

Keywords: BVS; DCB; OCT; in-scaffold restenosis.

Publication types

Case Reports

MeSH terms

Absorbable Implants*
Aged
Angioplasty, Balloon, Coronary / instrumentation*
Coronary Angiography
Coronary Restenosis / diagnosis
Coronary Restenosis / surgery*
Coronary Vessels / diagnostic imaging
Coronary Vessels / surgery*
Drug-Eluting Stents*
Humans
Immunosuppressive Agents / pharmacology
Male
Prosthesis Design
Sirolimus / pharmacology*
Tissue Scaffolds*
Tomography, Optical Coherence
Ultrasonography, Interventional

Substances

Immunosuppressive Agents
Sirolimus